Please login to the form below
33
Revenue 2017Humalog
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Humalog was produced by Lilly.
Lilly joins new Medicare scheme to reduce insulin prices
Lilly has faced particularly strong criticism, after its widely-used Humalog insulin rose from $34 to $234 per vial between 2001 and 2015.
Lilly will aim for one $1bn-$5bn deal per quarter in 2020
Lilly needs to refresh its pipeline as it continues to suffer from a decline across its older, established brands – including in its diabetes franchise, where its Humalog insulin is facing generic ... The company recently announced its will launch lower
Lilly extends range of cut-price insulins in the US
Cheaper, authorised generic versions of Lilly’s Humalog Junior KwikPen and Humalog Mix75/25 products – priced at $265.20 for a pack of five which is another 50% reduction on the ... Humalog pay less than $100 for their monthly prescription at retail
Novo follows Sanofi, Lilly with insulin price cut in US
which offered a 50% cheaper version of its Humalog (insulin lispro) the following month.
The fight for affordable insulin
The price of Humalog, more commonly used by type 1 patients, also saw its price rise 585% from $35 to $234 between 2001 and 2015. ... Lilly’s authorised generic. One company, Eli Lilly, has responded to the pleas for more affordable insulins, and
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Senior Account Manager
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Medical Editor
-
Competitive
-
Healthcare Account Director
-
Competitive
- PHE study finds people who have had COVID-19 can still transmit the virus
- Sanofi, GSK delay COVID-19 vaccine trial after underwhelming results in elderly participants
- Nucleus Global announces a trio of promotions
- PHE study finds people who have had COVID-19 can still transmit the virus
- AZ seeks EU approval for its Oxford University-partnered COVID-19 vaccine
- Valneva set to begin commercial manufacturing of COVID-19 vaccine within days
- Lilly’s antibody bamlanivimab cuts COVID-19 risk by up to 80%
- Gilead’s Jyseleca is given a NICE recommendation for rheumatoid arthritis
- Janet Woodcock named acting commissioner of the FDA
- Lateral flow tests detect ‘most infectious’ COVID-19 cases, Oxford researchers find
- 3 reasons why clinical trials will thrive in 2021
- #DemandDiversity: New research on COVID-19 clinical trial perceptions within minorities and high-risk populations
PMHub
Hamell
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...
Latest intelligence
- 3 reasons why clinical trials will thrive in 2021
- It’s not often that a single event can change the trajectory of an entire system, yet that is exactly what has happened to healthcare systems across the world and clinical...
- #DemandDiversity: New research on COVID-19 clinical trial perceptions within minorities and high-risk populations
- Lack of diversity in clinical trials still remains on of the biggest issues for COVID-19 clinical trials. But despite the growing discussions, calls for change, growing regulatory guidance and much...
- The pandemic preparedness paradox
- Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Quick links
Infographics
